在交出7年来最差利润成绩单后,白云山再报一季度营利双降

新快报
08 May

新快报讯去年因时任董事长被立案审查调查而备受关注的白云山,在新任董事长履职5个多月后,交出了2025年一季度营收净利双降的“成绩单”。而在今年3月,白云山才发布了2024年年报,-30%的净利润“雪崩”赫然在目。营利双降的颓势看似短期内难以扭转。2025年一季度营利双降,2024年业绩创近七年来新低日前,广州白云山医药集团股份有限公司公布2025年第一季度财报。报告期内,广州白云山营业收入为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10